NCT02370485View on ClinicalTrials.gov

A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Healthy
Interventions
DRUG

LY2801653

Administered orally

Trial Locations (1)

32117

Covance, Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02370485 - A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children | Biotech Hunter | Biotech Hunter